Propanc Biopharma Plans Phase 1b PRP Trial in Up to 50 Patients
Propanc Biopharma plans a Phase 1b PRP trial involving up to 50 advanced cancer patients.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Propanc Biopharma, Inc. (PPCB) Plans Q1 2027 Phase 1b PRP Trial; Raises $7.5M, Starts $5M Buyback
Propanc Biopharma reported $7.5M gross proceeds for FY25-26, began a $5.0M share repurchase program, and plans to start a Phase 1b first-in-human PRP study in Q1 2027 enrolling up to 50 advanced solid tumor patients.Material DetailsContext by AI AnalystThis is an early-stage biotech update combinin…